multifunctional oncolytic immunotherapy single-domain antibodies(Transgene)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namemultifunctional oncolytic immunotherapy single-domain antibodies(Transgene)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Recombinant vector vaccineBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTransgene Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTransgene Sa
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A